CH368161A - Process for the preparation of 11-amino steroids - Google Patents
Process for the preparation of 11-amino steroidsInfo
- Publication number
- CH368161A CH368161A CH6263558A CH6263558A CH368161A CH 368161 A CH368161 A CH 368161A CH 6263558 A CH6263558 A CH 6263558A CH 6263558 A CH6263558 A CH 6263558A CH 368161 A CH368161 A CH 368161A
- Authority
- CH
- Switzerland
- Prior art keywords
- amino
- steroids
- preparation
- solution
- hydroxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title description 5
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- -1 lithium aluminum hydride Chemical compound 0.000 claims description 7
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 150000002923 oximes Chemical class 0.000 claims description 5
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical compound [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 claims description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 229910052987 metal hydride Inorganic materials 0.000 claims description 2
- 150000004681 metal hydrides Chemical class 0.000 claims description 2
- 238000006146 oximation reaction Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 230000007935 neutral effect Effects 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000002329 infrared spectrum Methods 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000004043 oxo group Chemical group O=* 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- NPOMSUOUAZCMBL-UHFFFAOYSA-N dichloromethane;ethoxyethane Chemical compound ClCCl.CCOCC NPOMSUOUAZCMBL-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000006722 reduction reaction Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- QVZULXNXCIFMTL-IXCVKQQLSA-N 4802-74-8 Chemical compound O([C@@H]1[C@@H]([C@]2(CC(=O)[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QVZULXNXCIFMTL-IXCVKQQLSA-N 0.000 description 1
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical class [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003113 alkalizing effect Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006567 deketalization reaction Methods 0.000 description 1
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- DEQYTNZJHKPYEZ-UHFFFAOYSA-N ethyl acetate;heptane Chemical compound CCOC(C)=O.CCCCCCC DEQYTNZJHKPYEZ-UHFFFAOYSA-N 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical class OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- INLFWQCRAJUDCR-LYLBMTSKSA-N spirostane Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 INLFWQCRAJUDCR-LYLBMTSKSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
Verfahren zur Herstellung von 11-Amino-steroiden
Es wurde gefunden, dal3 man zu 11-Aminosteroiden gelangen kann, wenn man 11-Keto-steroide oximiert und die erhaltenen 11-Oxime reduziert.
Die gewonnenen 11-Amino-steroide sind neu und zeichnen sich durch interessante biologische Wirkungen aus ; ferner können sie als Zwischenprodukte für die Herstellung weiterer biologisch wirksamer Verbindungen Verwendung finden.
Für die Oximierung verwendet man Hydroxylamin oder seine Salze, z. B. das Hydrochlorid oder Acetat. Die Reaktion wird vorteilhaft bei erhöhter Temperatur, insbesondere in siedendem Tetrahydrofuran oder Dioxan, durchgeführt. Je nach dem verwendeten Ausgangsstoff benötigt man für die Beendigung der Reaktion etwa 1 bis 14 Tage. Die erhaltenen 11-Oximino-steroide sind gut kristallisierende, meist schwerlösliche Verbindungen und lassen sich durch Kristallisation aus geeigneten Lösungsmitteln, z. B. Aceton, Essigester, Methylenchlorid und Chloroform, reinigen.
Für die Reduktion der 11-Oximino-zur 11-Amino- gruppe stehen eine Reihe von Methoden zur Verfügung. So kann man die Reduktion mittels katalytisch angeregtem Wasserstoff, z. B. Wasserstoff in Gegenwart eines Platin-Katalysators in Eisessig-Lö- sung, mittels nascierendem Wasserstoff, z. B. Natrium oder Lithium in Gegenwart eines Alkohols, oder mittels geeigneten Leichtmetallhydriden, z. B.
Lithiumaluminiumhydrid, durchführen. Bei der katalytischen Hydrierung und der Reduktion mit Lithiumaluminiumhydrid erhält man zur Hauptsache die 11-Amino-steroide. Die Reduktion mittels Natrium und Alkohol, z. B. Isopropanol, liefert dagegen in überwiegender Menge die lla-Amino-steroide.
Die erhaltenen 11-Amino-steroide lassen sich in bekannter Weise in ihre Säureadditionssalze, z. B.
Hydrohalogenide, Chlorate, Perchlorate, Tartrate usw., überführen. Diese Salze eignen sich für die Herstellung wässriger Lösungen. Enthalten die gebildeten 11-Amino-steroide noch ketalisierte Oxogruppen, z. B. in 20-Stellung, so lassen sich diese in bekannter Weise, z. B. mittels saurer Hydrolyse, in freie Oxogruppen überführen.
Als Ausgangsstoffe für das vorliegende Verfahren eignen sich 11-Keto-steroide, die sich von den bekannten Steroidreihen, wie von der Cholestan-, Ergostan-, Sitostan-, Spirostan-, Cholan-, Bisnorcholan-, Atiocholan-, Pregnan-und Allopregnan-, Androstan-und Ostranreihe, oder von tetracyclischen Triterpenen (4,4,14-Trimethyl-steroide), z. B. vom Lanosterin, ableiten. Ausser der 11-Ketogruppe kön- nen die Ausgangsstoffe beliebige, weitere Substituenten aufweisen, wie freie oder veresterte oder ver ätherte Hydroxygruppen oder ketalisierte oder enolisierte Oxogruppen und Alkyl-, z. B. Methylgruppen.
Diese Substituenten sind insbesondere in den Stellungen 1, 2,3,4,6,9,12,17,20 und 21 vorhanden.
Die Ausgangsstoffe können im Ringsystem gesättigt sein oder Doppelbindungen aufweisen, beispielsweise in einer oder mehreren der Stellungen 1, 4,5,14,16 und 17,20. Die Ausgangsstoffe sind bekannt oder lassen sich nach an sich bekannten Methoden gewinnen.
Die Temperaturen sind in den nachfolgenden Beispielen in Celsiusgraden angegeben.
Beispiel 1 1 g 11-Keto-tigogenin, 10 gHydroxylamin-hydro- chlorid, 40 cm3 Pyridin und 80 cm3 abs. Athanol werden 1 Woche unter Rückfluss gekocht. Die Lösung wird dann unter vermindertem Druck zur Trockne eingedampft, der Rückstand in Wasser aufgeschlämmt, abfiltriert und bis zur neutralen Reaktion des Filtrates mit Wasser gewaschen. Man erhält 1,1 g eines Rohproduktes, das aus Essigester-Heptan umkristallisiert wird, wobei 0,35 g 11-Oximino- tigogenin vom F. 273-275 (unter Zersetzung) resultieren. IR-Spektrum : Banden bei 2,86 und 3,00, u (Hydroxyl) sowie 6,07 (Oxim).
Eine Lösung von 5 g 11-Oximino-tigogenin in 400 cm3 Tetrahydrofuran tropft man in eine Lösung von 10 g Lithiumaluminiumhydrid in 500 cm3 Tetrahydrofuran und kocht die Mischung 5 Tage unter Rühren in Stickstoffatmosphäre. Nach dem Abkühlen wird zur Zersetzung des überschüssigen Lithiumaluminiumhydrids vorsichtig Wasser zugetropft, die Reaktionslösung mit Salzsäure kongosauer gestellt und mit Methylenchlorid-Ather extrahiert. Dieser Extrakt liefert nach dem Verdampfen 2,16 g Neutralteil. Durch Alkalisieren der obigen salzsauren Lösung erhält man 1,64 g rohes 11-Amino-tigogenin, das sich durch Chromatographie an Aluminiumoxyd und Kristallisation aus Methanol auftrennen lässt.
Das llss-Amino-tigogenin schmilzt bei 182-183 , [a] 27=-560, das isomere lla-Amino-tigogenin bei 200-203 , [a] 2I7=-39 . Beide Isomeren liefern kristallisierte Hydrochloride.
Beispiel 2
1 g 3-Acetoxy-11-keto-20-äthylendioxy-ailo- pregnan, 10 g Hydroxylamin-hydrochlorid, 10 g Natriumhydroxyd und 150 cm3 abs. Athanol werden 20 Stunden unter Rückfluss gekocht. Dann wird das Gemisch erst unter atmosphärischem und später unter verringertem Druck zur Trockne eingedampft. Der Rückstand wird mit Wasser verrührt, auf einer Glasfilternutsche abfiltriert und bis zur neutralen Reaktion des Filtrats mit Wasser nachgewaschen. Das so erhaltene, getrocknete 34-Hydroxy-l l-oximino-20- äthylendioxy-allopregnan (0,86 g) wird aus Dioxan Ligroin kristallisiert und liefert dabei 0,75 g (80n/a) feiner Kristalle, die sich unterhalb 300 , ohne zu schmelzen, zersetzen.
IR-Spektrum : Banden bei 2,93 und 3,00, u (Hydroxyl), 6,08 u (Oxim).
Eine Lösung von 0,5 g 3, 6-Hydroxy-ll-oximino- 20-äthylendioxy-allopregnan in 50 cm3 Tetrahydrofuran wird in eine Lösung von 1 g Lithiumalumi- niumhydrid in 50 cm3 Tetrahydrofuran gegeben und die Mischung 6 Tage in Stickstoffatmosphäre gekocht. Nach der Aufarbeitung gemäss Beispiel 1 erhält man neben neutralen Anteilen 0,2 g 3jB-Hydroxy- l l, e-amino-20-äthylendioxy-allopregnan, das zwecks Ketalspaltung in 30 cm3 Aceton gelöst und nach Zugabe von 20 mg p-Toluolsulfonsäure 14 Stunden bei Raumtemperatur stehengelassen wird.
Nach Verdampfen der mit Natriumbicarbonat alkalisierten Reaktionslösung erhält man das 3fl-Hydroxy-Ilfl- amino-20-keto-allopregnan, das nach Umkristallisieren aus Methylenchlorid-Ather bei 191-195 schmilzt. Das Präparat ist in Form seiner Salze wasserlöslich.
Beispiel 3
500 mg 3jss-Hydroxy-ll-keto-lanostan, 4 g Hydroxylamin-hydrochlorid, 20 cm3 Pyridin und 40 cm3 abs. Athanol werden 14 Tage unter Rückfluss gekocht. Die Lösung wird dann unter vermindertem Druck zur Trockne eingeengt, der Rückstand in Äther aufgenommen und mehrmals mit Wasser gewaschen, wobei das Waschwasser noch jeweils zweimal mit Äther nachextrahiert wird. Nach der Aufarbeitung erhält man 510 mg rohes 3ss-Hydroxy-ll- oximino-lanostan. Dieses wird aus Methylenchlorid Methanol umkristallisiert, F. 211-213 . IR-Spektrum : Banden bei 2,79 und 2,95 (Hydroxyl), 6,07 a (Oxim) (Nujol).
Durch Reduktion des 3ss-Hydroxy-ll-oximino- lanostans nach den Angaben im Beispiel 1 erhält man das 3ss-Hydroxy-ll-amino-lanostan.
Beispiel 4
Eine Lösung von 1 g 3ss-Acetoxy-11, 20-diketo allopregnan und 10 g Hydroxylamin-hydrochlorid in 40 cm3 Pyridin und 80 cm3 abs. Athanol wird 6 Tage unter Rückfluss gekocht. Die Lösung wird dann unter vermindertem Druck zur Trockne eingedampft, der Rückstand in Wasser aufgeschlämmt, abfiltriert und bis zur neutralen Reaktion des Filtrats mit Wasser nachgewaschen. Das so abfiltrierte rohe 3ss-Acetoxy-11, 20-dioximino-allopregnan wird aus Methylenchlorid-Methanol umkristallisiert, Ausbeute : 0,54 g, F. 249-253 . IR-Spektrum : Banden bei 3,07 ti (Oxim-OH), 5,80 und 8,03 a (Acetat), 6,06, u (Oxim).
Durch Reduktion des erhaltenen 11,20-Dioxims analog den Angaben in Beispiel 1 gelangt man zum 3ss-Hydroxy-11, 20-diamino-allopregnan.
Process for the preparation of 11-amino steroids
It has been found that 11-aminosteroids can be obtained if 11-keto-steroids are oximated and the 11-oximes obtained are reduced.
The 11-amino steroids obtained are new and are characterized by interesting biological effects; they can also be used as intermediates for the preparation of other biologically active compounds.
For the oximation one uses hydroxylamine or its salts, z. B. the hydrochloride or acetate. The reaction is advantageously carried out at an elevated temperature, in particular in boiling tetrahydrofuran or dioxane. Depending on the starting material used, it takes about 1 to 14 days to complete the reaction. The 11-oximino steroids obtained are readily crystallizing, mostly sparingly soluble compounds and can be crystallized from suitable solvents, e.g. B. acetone, ethyl acetate, methylene chloride and chloroform, clean.
A number of methods are available for the reduction of the 11-oximino to the 11-amino group. So you can reduce by means of catalytically excited hydrogen, z. B. hydrogen in the presence of a platinum catalyst in glacial acetic acid solution, using nascent hydrogen, z. B. sodium or lithium in the presence of an alcohol, or by means of suitable light metal hydrides, e.g. B.
Lithium aluminum hydride. In the catalytic hydrogenation and reduction with lithium aluminum hydride, the 11-amino-steroids are mainly obtained. The reduction using sodium and alcohol, e.g. B. Isopropanol, on the other hand, supplies the predominant quantities of the IIIa-amino steroids.
The 11-amino steroids obtained can be converted into their acid addition salts in a known manner, e.g. B.
Hydrohalides, chlorates, perchlorates, tartrates, etc., transfer. These salts are suitable for the preparation of aqueous solutions. If the 11-amino steroids formed still contain ketalized oxo groups, e.g. B. in the 20 position, this can be done in a known manner, for. B. by means of acid hydrolysis, converted into free oxo groups.
Suitable starting materials for the present method are 11-keto-steroids, which are from the known steroid series, such as the Cholestan-, Ergostan-, Sitostan-, Spirostan-, Cholan-, Bisnorcholan-, Atiocholan-, Pregnan- and Allopregnan- , Androstane and ostran series, or of tetracyclic triterpenes (4,4,14-trimethyl steroids), e.g. B. from lanosterol. In addition to the 11-keto group, the starting materials can have any further substituents, such as free or esterified or etherified hydroxyl groups or ketalized or enolized oxo groups and alkyl, e.g. B. methyl groups.
These substituents are particularly present in the 1, 2, 3, 4, 6, 9, 12, 17, 20 and 21 positions.
The starting materials can be saturated in the ring system or have double bonds, for example in one or more of the positions 1, 4, 5, 14, 16 and 17, 20. The starting materials are known or can be obtained by methods known per se.
In the examples below, the temperatures are given in degrees Celsius.
Example 1 1 g of 11-ketotigogenin, 10 g of hydroxylamine hydrochloride, 40 cm3 of pyridine and 80 cm3 of abs. Ethanol are refluxed for 1 week. The solution is then evaporated to dryness under reduced pressure, the residue is suspended in water, filtered off and washed with water until the filtrate reacts neutral. 1.1 g of a crude product are obtained, which is recrystallized from ethyl acetate-heptane, 0.35 g of 11-oximino-tigogenin having a melting point of 273-275 (with decomposition). IR spectrum: bands at 2.86 and 3.00, u (hydroxyl) and 6.07 (oxime).
A solution of 5 g of 11-oximino-tigogenin in 400 cm3 of tetrahydrofuran is added dropwise to a solution of 10 g of lithium aluminum hydride in 500 cm3 of tetrahydrofuran and the mixture is boiled for 5 days while stirring in a nitrogen atmosphere. After cooling, water is carefully added dropwise to decompose the excess lithium aluminum hydride, the reaction solution is made acidic to Congo with hydrochloric acid and extracted with methylene chloride-ether. After evaporation, this extract provides 2.16 g of neutral. By alkalizing the above hydrochloric acid solution, 1.64 g of crude 11-amino-tigogenin are obtained, which can be separated by chromatography on aluminum oxide and crystallization from methanol.
The IIss-amino-tigogenin melts at 182-183, [a] 27 = -560, the isomeric IIIa-amino-tigogenin at 200-203, [a] 217 = -39. Both isomers yield crystallized hydrochlorides.
Example 2
1 g of 3-acetoxy-11-keto-20-ethylenedioxy-ailo-pregnane, 10 g of hydroxylamine hydrochloride, 10 g of sodium hydroxide and 150 cm3 of abs. Ethanol are refluxed for 20 hours. The mixture is then evaporated to dryness, first under atmospheric and later under reduced pressure. The residue is stirred with water, filtered off on a glass suction filter and washed with water until the filtrate reacts neutral. The dried 34-hydroxy-l-oximino-20-ethylenedioxy-allopregnane obtained in this way (0.86 g) is crystallized from dioxane ligroin and gives 0.75 g (80n / a) of fine crystals which are below 300, decompose without melting.
IR spectrum: bands at 2.93 and 3.00, u (hydroxyl), 6.08 u (oxime).
A solution of 0.5 g of 3,6-hydroxy-ll-oximino-20-ethylenedioxy-allopregnane in 50 cm3 of tetrahydrofuran is added to a solution of 1 g of lithium aluminum hydride in 50 cm3 of tetrahydrofuran and the mixture is boiled for 6 days in a nitrogen atmosphere. After working up according to Example 1, in addition to neutral components, 0.2 g of 3jB-hydroxy-II, e-amino-20-ethylenedioxy-allopregnane is obtained, which is dissolved in 30 cm3 of acetone for the purpose of ketal cleavage and after addition of 20 mg of p-toluenesulfonic acid for 14 hours is allowed to stand at room temperature.
After evaporation of the reaction solution alkalized with sodium bicarbonate, 3fl-hydroxy-Ilfl-amino-20-keto-allopregnane is obtained, which, after recrystallization from methylene chloride-ether, melts at 191-195. The preparation is water-soluble in the form of its salts.
Example 3
500 mg 3jss-hydroxy-II-keto-lanostane, 4 g hydroxylamine hydrochloride, 20 cm3 pyridine and 40 cm3 abs. Ethanol are refluxed for 14 days. The solution is then concentrated to dryness under reduced pressure, the residue is taken up in ether and washed several times with water, the wash water being re-extracted twice with ether each time. After working up, 510 mg of crude 3ss-hydroxy-ll-oximino-lanostane are obtained. This is recrystallized from methylene chloride, methanol, mp 211-213. IR spectrum: bands at 2.79 and 2.95 (hydroxyl), 6.07 a (oxime) (Nujol).
By reducing the 3ss-hydroxy-ll-oximino-lanostane according to the information in Example 1, the 3ss-hydroxy-ll-amino-lanostane is obtained.
Example 4
A solution of 1 g of 3ss-acetoxy-11, 20-diketo allopregnan and 10 g of hydroxylamine hydrochloride in 40 cm3 of pyridine and 80 cm3 of abs. Ethanol is refluxed for 6 days. The solution is then evaporated to dryness under reduced pressure, the residue is suspended in water, filtered off and washed with water until the filtrate reacts neutral. The crude 3ss-acetoxy-11, 20-dioximino-allopregnane filtered off in this way is recrystallized from methylene chloride-methanol, yield: 0.54 g, melting point 249-253. IR spectrum: bands at 3.07 ti (oxime-OH), 5.80 and 8.03 a (acetate), 6.06, u (oxime).
By reducing the 11,20-dioxime obtained analogously to the information in Example 1, 3ss-hydroxy-11,20-diamino-allopregnane is obtained.
Claims (1)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH6263558A CH368161A (en) | 1958-08-06 | 1958-08-06 | Process for the preparation of 11-amino steroids |
DEC19488A DE1110161B (en) | 1958-08-06 | 1959-07-28 | Process for the preparation of aminosteroids |
FR801981A FR1271490A (en) | 1958-08-06 | 1959-08-04 | Process for the preparation of new 11-amino-steroids |
NL242027A NL105748C (en) | 1958-08-06 | 1959-08-05 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH6263558A CH368161A (en) | 1958-08-06 | 1958-08-06 | Process for the preparation of 11-amino steroids |
Publications (1)
Publication Number | Publication Date |
---|---|
CH368161A true CH368161A (en) | 1963-03-31 |
Family
ID=4524417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH6263558A CH368161A (en) | 1958-08-06 | 1958-08-06 | Process for the preparation of 11-amino steroids |
Country Status (4)
Country | Link |
---|---|
CH (1) | CH368161A (en) |
DE (1) | DE1110161B (en) |
FR (1) | FR1271490A (en) |
NL (1) | NL105748C (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10000527B2 (en) | 2013-12-12 | 2018-06-19 | Council Of Scientific And Industrial Research | 11-substituted bile acid derivatives, process for the preparation thereof and use of these compounds as medicaments |
-
1958
- 1958-08-06 CH CH6263558A patent/CH368161A/en unknown
-
1959
- 1959-07-28 DE DEC19488A patent/DE1110161B/en active Pending
- 1959-08-04 FR FR801981A patent/FR1271490A/en not_active Expired
- 1959-08-05 NL NL242027A patent/NL105748C/xx active
Also Published As
Publication number | Publication date |
---|---|
NL105748C (en) | 1963-08-15 |
DE1110161B (en) | 1961-07-06 |
FR1271490A (en) | 1961-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH368161A (en) | Process for the preparation of 11-amino steroids | |
DE1131665B (en) | Process for the preparation of aminosteroid compounds | |
DE1260466B (en) | Process for the preparation of 17-oxo-D-homo-5alpha or 17-oxo-D-homo-5alpha, 13alpha-18-acids or their methyl esters | |
DE2013032B2 (en) | 3-Amino-cardenoIide, process for their preparation and their use in combating cardiovascular diseases | |
CH537913A (en) | Delta5 10-3-keto-19-norsteroids | |
DE1943901C3 (en) | Cardenolide-3- [2 ', 3' - dideoxyglycosides] and processes for their preparation, and the use of these compounds for combating heart diseases | |
DE963517C (en) | Process for the preparation of antipyretic and analgesic effective, basic substituted phenyldimethylpyrazolone derivatives | |
DE1643048C3 (en) | Process for the production of 3 ß-hydroxy-A5 (10) -steroids | |
DE930565C (en) | Process for the preparation of 1-phenyl-2-amino-1, 3-propanediols or of 1-phenyl-2-amino-1, 3-propanediols substituted in the phenyl radical | |
CH500958A (en) | Process for making steroid compounds | |
DE1264441B (en) | Process for the production of 17alpha-AEthynyl-delta 5 (10-19-nor-androsten-17beta-ol-3-one and 17alpha-AEthynil-19-nor-testosterone and its esters | |
AT265540B (en) | Process for the manufacture of new steroids | |
DE1120447B (en) | Process for the preparation of 17ª-oxy-16-methylenepregn-4-en-3, 20-dione or its acyl derivatives | |
DE1618747C3 (en) | Process for the preparation of Delta to the power of 5 (10) 3-keto-19-nor-steroids | |
AT233184B (en) | Process for the preparation of 3-oxo-Δ <1,4> steroids | |
DE730996C (en) | Process for the preparation of carboxylic acids of the cyclopentano-polyhydrophenanthrene series | |
AT257060B (en) | Process for the preparation of new 3-enol ethers of the 6-methyl-3-oxo-Δ <4> -steroids of the androstane, 19-norandrostane, pregnane and 19-norpregnane series | |
DE1904896A1 (en) | New chemical compound | |
CH378877A (en) | Process for the production of 4-3-keto-6a-methylsteroids | |
AT249892B (en) | Process for the preparation of 3-oxo-Δ <4> -6-methyl-steroids | |
AT226231B (en) | Process for the preparation of the stereoisomeric forms of the new, racemic 2-phenyl-2-piperidyl- (2) -ethanol | |
DE2003653B2 (en) | Process for the preparation of pregnan-20-one-3beta, 5beta, 14beta, 21-tetrol or its 3,21-di-tetrahydropyranyl ether and the corresponding intermediates | |
DE1022574B (en) | Process for the preparation of 1-amino-1-deoxy-2-ketoses and their salts | |
DE1252679B (en) | Process for the preparation of zlM.5 (10) -A-homo-oestratrien-3-one derivatives | |
DE1158965B (en) | Process for the preparation of 3ª ‡ - or 3ª ‰ -hydroxy- or -acyloxy-20-methylamino compounds of the pregnan, allopregnan or 5-pregnene series |